Kelyniam Global, Inc. (KLYG)
OTCMKTS · Delayed Price · Currency is USD
0.0700
0.00 (0.00%)
Aug 21, 2025, 4:00 PM EDT
Kelyniam Global Market Cap
Kelyniam Global has a market cap or net worth of $3.51 million as of August 22, 2025. Its market cap has increased by 33.22% in one year.
Market Cap
3.51M
Enterprise Value
4.14M
Revenue
2.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
Market Cap Chart
Since April 3, 2008, Kelyniam Global's market cap has decreased from 5.24M to 3.51M, a decrease of -32.96%. That is a compound annual growth rate of -2.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2025 | 3.51M | -54.97% |
| Dec 31, 2024 | 7.80M | 327.63% |
| Dec 28, 2023 | 1.83M | -24.53% |
| Dec 27, 2022 | 2.42M | -4.56% |
| Dec 31, 2021 | 2.53M | -37.32% |
| Dec 28, 2020 | 4.04M | 49.66% |
| Dec 17, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 632.06M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.33M |
| Northwest Biotherapeutics | 366.64M |